Marketing attribution ROI benchmarks and payback periods for healthcare and life sciences in the Middle East

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the Middle East. In this market, Middle Eastern buyers reward in-person credibility, sovereign fit, and patient sequencing, so the way you install marketing attribution has to be shaped to that reality from day one.

Payback is the honest ROI question for marketing attribution: how many months from first dollar spent to first dollar returned. Below are the ranges we see, split by category and starting condition.

Best-case payback for marketing attribution in a category with warm demand: 60–90 days. Median: 4–6 months. Cold category with no warm inbound: 6–9 months.

The dominant driver of payback is trigger quality, not spend. You cannot allocate spend against a number you don't trust — teams that respect this get inside the shorter range.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the Middle East it is compounded by the fact that senior-relationship access, not product is what actually gates growth. Marketing attribution is only useful here when it is pointed at both constraints at once.

Attribution model reconciled to closed-won is the leading indicator. If it moves inside the first six weeks, payback usually lands in the best case. If it stalls for a month, replan.

ROI compounds after payback. By month 12, well-run marketing attribution functions typically produce 3–5x return on total cost of ownership.

Bad ROI has one signature: picking a model to defend a budget instead of to learn. Where you see broken payback, you see this pattern almost every time.

Benchmarks are useful as a sanity check, not a target. The target is the one your finance team commits to on the current-year plan; benchmarks tell you if that target is plausible.

Concretely for healthcare and life sciences in the Middle East: the healthcare teams that install this get past procurement instead of dying in it, and one sovereign or family-office win in the Middle East justifies a full year of program spend. That is the reason it is worth installing marketing attribution deliberately for this market rather than importing a playbook designed for somewhere else.